NCT00860873

Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis

Randomized Study of Two Dosage Forms (Oral Powder and Capsule) of "Chondroitin + Glucosamine Sulfate" Produced by the Laboratory EMS When Compared to the Product Condroflex (Oral Powder and Capsules) Produced by Laboratory Zodiac in the Treatment of Osteoarthrosis.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 280 (actual)
• Sponsor: Azidus Brasil · Industry
• Sex: All
• Age: 30 Years – 80 Years
• Healthy volunteers: Accepted

Summary

This study objective is to check the non-inferiority of the 2 formulations produced by EMS when compared with the same substances and pharmaceuticals forms of the product Condroflex (Zodiac), by promoting the relief of osteoarthrosis symptoms such as pain, stiffness and functional capacity that will be periodically measured by using the "Visual Analog Scale" of pain (VAS) and the questionnaire of Lequesne.

Conditions

• Osteoarthrosis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	EMS Chondroitin Sulfate + Glucosamine Sulfate (Oral powder)	Chondroitin Sulfate 1200mg Glucosamine Sulfate 1500mg
DIETARY_SUPPLEMENT	EMS Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (hard capsules)	Chondroitin Sulfate 1200mg Glucosamine Sulfate 1500mg
DIETARY_SUPPLEMENT	Zodiac: Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (Oral powder)	Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg
DIETARY_SUPPLEMENT	Zodiac Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (hard capsules)	Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg

Timeline

• Start date: 2009-10-01
• Primary completion: 2009-11-01
• Completion: 2010-11-01
• First posted: 2009-03-12
• Last updated: 2013-02-25

Locations

1 site across 1 country: Brazil